McKinsey & Co. explains that an insights-driven approach by doctors, providers and caregivers can help patients follow treatment regimens. It contends that the traditional approach of using a handful of interventions to encourage medication adherence, which addresses all patients equally, may be costing the healthcare system billions of dollars in potentially ineffective interventions. The firm contends that drugmakers can take cues from the retail, banking, and technology industries to create a 360-degree perspective of patients' lives to identify contributing factors to non-adherence, such as behavioral patterns, demographics, and lifestyle choices. Insurers, providers, drugmakers and data aggregators have access to data that can help predict behavioral and allow for tailored interventions, and McKinsey says direct-to-patient channels, such as patient hubs and social media, can be used to reach patients directly with interventions to improve adherence. It contends the healthcare sector can use a three-step approach to increase patient adherence:
- Predicting which patients are most likely to lapse on their treatments,
- Tailoring interventions for patients who need the most support, and
- Building agile teams to deliver personalized interventions to individual patients when needed.